Mira Pharmaceuticals Files 8-K for Other Events
Ticker: MIRA · Form: 8-K · Filed: Sep 15, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Sep 15, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, regulatory-filing
TL;DR
Mira Pharma filed an 8-K for 'Other Events' - details TBD.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on September 15, 2025, reporting "Other Events." The company, formerly known as Mira1a Therapeutics, Inc. until January 12, 2022, is incorporated in Florida and headquartered in Miami. The filing does not disclose specific details about the "Other Events" but provides standard company information.
Why It Matters
This 8-K filing indicates Mira Pharmaceuticals has reported an event requiring immediate disclosure to the SEC, though the specific nature of the event is not detailed in the provided text.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events,' which can range from minor administrative changes to significant corporate developments, making the immediate risk unclear without further information.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former company name
- September 15, 2025 (date) — Date of report
- Florida (location) — State of incorporation
- Miami (location) — Principal executive office city
- 1200 Brickell Avenue, Suite 1950 #1183 (address) — Principal executive office address
- 001-41765 (identifier) — SEC file number
- 85-3354547 (identifier) — IRS Employer Identification No.
FAQ
What specific 'Other Events' are being reported by Mira Pharmaceuticals, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on September 15, 2025.
What was Mira Pharmaceuticals, Inc. formerly known as?
Mira Pharmaceuticals, Inc. was formerly known as Mira1a Therapeutics, Inc.
On what date did the company change its name from Mira1a Therapeutics, Inc.?
The company changed its name from Mira1a Therapeutics, Inc. on January 12, 2022.
Where is Mira Pharmaceuticals, Inc. headquartered?
Mira Pharmaceuticals, Inc. is headquartered at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
Filing Stats: 664 words · 3 min read · ~2 pages · Grade level 14.5 · Accepted 2025-09-15 16:02:29
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MIRA The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 35KB
- 0001493152-25-013459.txt ( ) — 199KB
- mira-20250915.xsd (EX-101.SCH) — 3KB
- mira-20250915_lab.xml (EX-101.LAB) — 33KB
- mira-20250915_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIRA PHARMACEUTICALS, INC. Dated: September 15, 2025 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer